Midland Pharmaceuticals launches to advance spinal injury therapeutics
Scientists from the universities of Birmingham and Sheffield have partnered with NLC Health Ventures for the launch of Midland Pharmaceuticals to focus on the development of a new therapeutic for spinal cord injury and cerebrovascular disease, including …